Dispensing Cannabis business knowledge beyond a million square feet of cultivation space. Blunt Business navigates the challenges and opportunities of one of the most profitable industries on earth. Join us each episode to hear our weekly round tables and interviews with industry professionals.
Subscribe:.rss.atom.json.md.m3u.pls
Overdue Last read · next check
Last read 22 hours ago, longer than this feed's 7 hours schedule.
Saves to your Listen queue, to pick up on another day or another device.
As the 2026 midterm elections approach, marijuana reform is proving to be a rare unifying force across the political spectrum. Driven by high-stakes federal rescheduling efforts and a fresh wave of state-level ballot measures, cannabis policy has evolved from a fringe topic into a mainstream, bipartisan priority. Politicians on both sides of the aisle are increasingly recognizing that "the green…
As the legal cannabis sector eagerly awaits federal reclassification judgments, industry players are aggressively pivoting toward untapped markets and hesitant, first-time consumers. In California, dispensaries are tearing down old retail friction points by introducing state-approved self-checkout kiosks equipped with multi-product RFID scanners, mimicking the familiarity and efficiency of…
Although the historic DEA rescheduling hearings have officially concluded, the administrative process has ended without an immediate, final ruling, leaving the federal status of cannabis temporarily in limbo. Despite the lack of a definitive outcome, the hearings marked a monumental breakdown in federal policy: medical cannabis operators are emerging as clear near-term winners due to the immediate…
As the DEA moves toward rescheduling cannabis, the industry is bracing for a complex transformation defined by regulatory uncertainty and potential legal headwinds. While federal agencies have taken an unexpectedly active role in supporting this transition, the timeline for full implementation remains long and subject to likely legal challenges. Blunt Business speaks with Chris Lynch, partner at…
Joe Bayern with MM Brands outlines a strategic roadmap for professionalizing the cannabis industry, emphasizing that sustainable growth requires moving beyond fragmented operations. Key strategies include adopting a portfolio-based management model to share operational and manufacturing costs, implementing minimalist, needs-based branding to simplify the consumer experience, and navigating…
Blunt Business welcomes Joe Bayern, the CEO of MM Brands to discuss how the cannabis industry is approaching a potential turning point as DOJ and DEA hearings conclude this July, with anticipation high for a move to Schedule 3 classification. This reclassification could eliminate 280E tax constraints, driving better profitability, while FDA validation of therapeutic benefits promises to reduce…
Once again we welcome back Nick Richards, Partner and co-chair of the cannabis law practice group at Greenspoon Marder about how the cannabis and hemp industries currently face a complex landscape defined by existential regulatory threats and critical federal proceedings. Financial institutions are increasingly wary, with potential hemp reclassification jeopardizing banking access and subjecting…
The sports industry is witnessing a landmark normalization of cannabis, highlighted by the WNBA’s recent collective bargaining agreement which removed cannabis from its prohibited substances list in favor of supportive substance abuse treatment programs. While this signals a new era for athlete endorsements and professional branding, the broader cannabis and hemp sector faces a precarious future.…
We report on a wave of highly targeted legislative, legal, and medical updates aimed at curbing market disorder and protecting public health. In the United States, Virginia has advanced a budget deal to its governor establishing a definitive July 2027 timeline for adult-use dispensary sales, while Illinois has enacted precise safety guardrails by banning intoxicating hemp sales to minors and…
Dr. Priyanka Sharma, co-CEO of Kazmira Therapeutics and fellow co-CEO Pulak Sharma, cut through the confusion surrounding the rapidly evolving cannabis and hemp sectors. She clarifies the critical distinction between THCA—the non-intoxicating precursor that converts to THC upon heating—and delta-9 THC, noting that current marketing often masks the potential intoxicating effects of heated THCA…
